Anlon Healthcare Limited (AHCL) reports 163% topline growth, 150% EBITDA growth and 133% PAT growth in Q1 FY27, strengthening its integrated pharmaceutical p.
Anlon Healthcare Limited (AHCL) reports 43% revenue growth and 48% EBITDA surge in Q4 FY26, driven by strategic acquisitions and robust R&D.